top of page

Podcast

Oct 29, 2025

Striking the right balance between risk and innovation with Marek Wasiluk

Sylvain Berthelot welcomes Dr. Marek Wasiluk, CEO of ClinMark. With a career that spans from CRA to leading a global CRO, Marek brings a unique perspective on how clinical research organizations can embrace innovation while safeguarding trial quality.

Together, they explore the fine balance between adopting new technologies and managing operational risk. Marek shares how his background in medicine, quality assurance, and clinical operations shapes his approach to implementing digital solutions that not only meet regulatory expectations but also bring real value to sponsors and patients.

Sylvain and Marek discuss why CROs must be both cautious and bold when evaluating new tools, how to build trust with clients while innovating, and the importance of curiosity and adaptability in driving meaningful change.

Tune in to hear how CROs can move beyond “shiny new objects” and take a thoughtful, balanced approach to innovation in clinical trials.

placeholder_white_300x300.jpg

Share via

See CRScube in action

Explore how our platform will elevate your team and clinical trial management.

crscube_in_action_ca.avif

Get insights straight to your inbox

img_001.avif

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

Featured resources

icon_01.png

Why clinical teams transition from legacy systems to CRScube

As the industry moves toward faster, more decentralized models, many teams find that the tools which once supported them now require significant manual workarounds to stay current.

icon_01.png

From "Wow" to "How": What your questions taught us about the future of AI in clinical trials

While presenting our AI-led EDC setup functionality, we were impressed by the questions asked and what they reveal about our clients' readiness for AI-driven technology.

icon_01.png

Beyond integration: How a unified eClinical platform transforms signal detection into site action

For Lead CRAs and CRAs, a unified eClinical platform can shorten the path from risk identification to site action, reducing the delays and inefficiencies caused by disconnected systems.

bottom of page